Skip to main content
IMMP logo

Immutep Limited

IMMPNASDAQHealthcareBiotechnology

$3.15Today:- (-)1Y +57.71%

As of Oct 27, 2026 close

Market cap
$463.55M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.29$9.18
Volume (live)
-
Avg. volume (3M)
20.14K

Immutep (IMMP) Income Statement

Immutep reported revenue of AUD 14.56M in fiscal 2026 (fiscal year ended Jun 30, 2026), up 188.6% from AUD 5.04M a year earlier. Immutep posted a net loss of AUD 79.30M, compared with a net loss of AUD 61.43M a year earlier. Gross margin was 81.2% and operating margin -560.5%.

Immutep Income Statement Analysis

Values in billions AUD

Scroll to see more
Immutep Limited income statement - Annual data in billions AUD
BreakdownFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 2026Jun 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Revenue & Gross Profit
Revenue0.010.010.000.000.000.000.010.000.000.00
Cost of Revenue0.090.060.040.040.030.020.020.020.010.00
Gross Profit0.01-0.060.000.000.00-0.01-0.01-0.02-0.010.00
Operating Expenses
Research & Development0.090.060.040.040.030.020.020.020.010.01
Selling, General & Administrative0.010.010.010.010.010.010.010.010.010.00
Operating Expenses0.100.070.050.040.040.020.020.020.010.01
Operating Income-0.08-0.13-0.05-0.04-0.04-0.03-0.02-0.02-0.01-0.01
Other Income/Expense
Interest Income0.000.010.000.000.000.000.000.000.000.00
Interest Expense0.000.000.000.000.000.000.000.000.000.00
Other Income/Expense0.000.060.010.000.010.000.000.000.010.00
Income
Income Before Tax-0.08-0.06-0.04-0.04-0.03-0.03-0.01-0.02-0.01-0.01
Income Tax Expense0.000.000.000.000.000.000.000.000.000.00
Net Income-0.08-0.06-0.04-0.04-0.03-0.03-0.01-0.02-0.01-0.01
Net Income - Continuous Operations-0.08-0.06-0.04-0.04-0.03-0.03-0.01-0.02-0.01-0.01
Net Income - Discontinued Operations----------
EBITDA-0.08-0.06-0.04-0.04-0.03-0.02-0.01-0.02-0.01-0.01
EBIT-0.08-0.07-0.05-0.04-0.03-0.02----
Depreciation & Amortization0.000.000.000.000.000.000.000.000.000.00
Earnings Per Share
Basic EPS-1.00-8.00--9.00--10.00-7.00-9.00-10.00-9.00
Diluted EPS-1.00-8.00--9.00--10.00-7.00-9.00-10.00-9.00
Basic Shares Outstanding0.150.011.200.000.850.000.000.000.000.00
Diluted Shares Outstanding0.150.011.200.000.850.000.000.000.000.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immutep Financial Statements

What was Immutep's revenue in fiscal 2026?

Immutep reported revenue of AUD 14.56M in fiscal 2026 (fiscal year ended Jun 30, 2026). That was up 188.6% from AUD 5.04M a year earlier.

Is Immutep profitable?

No. Immutep reported a net loss of AUD 79.30M in fiscal 2026. In fiscal 2025 it lost AUD 61.43M.

What is Immutep's operating margin?

Immutep's operating income was −AUD 81.59M on revenue of AUD 14.56M in fiscal 2026, an operating margin of -560.5%, compared with -2506.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition